Inactive Instrument

Other languages SYNTH MR Swiss Exchange

Equities

SE0005454865

End-of-day quote Swiss Exchange Other stock markets
- ^SEK	-

22/05	SyntheticMR AB Announces Board Changes	CI
21/05	SyntheticMR AB Provides Earnings Guidance for the Year 2024	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

SyntheticMR AB Announces Board Changes	22/05
SyntheticMR AB Provides Earnings Guidance for the Year 2024	21/05
SyntheticMR AB Reports Earnings Results for the First Quarter Ended March 31, 2024	21/05
SyntheticMR AB and SimonMed Imaging Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from Synthetic Software at SimonMed Facilities	17/04
SyntheticMR Receives FDA 510(k) Clearance for Their Next Generation Solution SyMRI 3D	27/03
Royal Philips Partners SyntheticMR to Roll Out New Brain Disorder Diagnosis Technology	01/03
Syntheticmr AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	20/02
SyntheticMR AB Reports Earnings Results for the Full Year Ended December 31, 2023	20/02
SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-Marking	18/12
SyntheticMR Receives Order from an OEM Partner	13/12
SyntheticMR and Philips Announces Expands Global Partnership for SyMRI 3D	30/11
SyntheticMR Has Submitted Their Next Generation Solution, SyMRI 3D for 510(K) Clearance	22/11
SyntheticMR Appoints Nomination Committee for the 2024 Annual General Meeting	17/11
SyntheticMR AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11
SyntheticMR AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22/23/22
SyntheticMR Releases A New Update to SyMRI 11.3.11 & 12.1.11	15/23/15
SyntheticMR Introduces Quantitative Neuro Reports to Enhance Clinical Workflow	13/23/13
SyntheticMR Receives Regulatory Approval for Their Innovative SyMRI Software Solution in South Korea	31/23/31
SyntheticMR AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23/23/23
SyntheticMR's Receives Regulatory Clearance for SyMRI in the UK	02/23/02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages SYNTH MR Swiss Exchange

Equities

SE0005454865

Other languages

Filters